Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Naloxone benzoylhydrazone is an antagonist of μ-, κ1-, and δ-opioid receptors (pA2s = 8.82, 7.45, and 7.76, respectively, for the mouse receptors).1 It is also an agonist of the κ3-opioid receptor (IC50 = 0.7 nM for the guinea pig receptor). Naloxone benzoylhydrazone (1 µg/animal, i.c.v.) inhibits increases in the latency to tail withdrawal induced by the μ-opioid receptor agonist DAMGO (Item No. 21553) in a hot plate assay in mice.2 It increases food intake in rats when intracerebrally administered at doses of 0.1, 1, and 20 µg/animal.3
WARNING This product is not for human or veterinary use.
1. The in vitro pharmacological characterization of naloxone benzoylhydrazone. Eur. J. Pharmacol. 277(2-3), 257-263 (1995).
2. Naloxone benzoylhydrazone (NalBzoH) analgesia. J. Pharmacol. Exp. Ther. 255(2), 769-774 (1990).
3. Naloxone benzoylhydrazone, a ᴋ3 opioid agonist, stimulates food intake in rats. Brain. Res. 581(2), 311-314 (1992).